Search

everythinglearnresearchcommunity

for

Search:↓

New hair transplant methods offer more natural results and better graft survival, with ongoing research to increase donor hair options.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Women with female pattern hair loss often underestimate how severe it is.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Finasteride potentially treats hair loss by reducing DHT production.

Finasteride given to baby rats causes anxiety-like behavior and worsens learning from punishment in adult rats.

Testosterone improves mood and thinking skills; finasteride has no effect.

Testosterone applied to rabbit skin increases skin cell growth and changes skin structure.

Gene linked to common hair loss found, may lead to new treatments.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Finasteride reduces alcohol withdrawal severity and anxiety in mice, but may increase withdrawal severity in some cases.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Finasteride slows down motherly behavior in first-time pregnant rats.

Lasers, microneedling, and PRP improve skin rejuvenation and repair, with PRP enhancing the effects when combined with other treatments.

The Beverly Hills Diet is unscientific, potentially harmful, and could cause serious health issues.

Scientists have made progress in understanding hair follicle stem cells, identifying specific genes and markers, and suggesting their use in treating hair and skin conditions.

Deleting the Far2 gene in mice causes sebaceous gland issues and patchy hair loss.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Half of hair restoration surgeons experience body discomfort, especially after follicular unit extraction procedures, and using ergonomic equipment or robotic devices could reduce this discomfort.

A new mutation in the hairless gene causes hair loss and skin wrinkling in mice.

Too much zinc in the diet can cause hair loss and color change in young mice by reducing copper in the body.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

A woman's ovarian tumor causing high testosterone was successfully removed, and her symptoms improved.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Using microscopes in hair transplants reduces follicle damage.

A woman with EMS showed unusual skin mucinosis without the typical hard skin syndrome, suggesting EMS can cause skin mucinosis.

Most people using minoxidil for hair loss probably won't see significant improvement.

An 8-year-old girl with Rapunzel syndrome had a hairball removed from her stomach and intestines and recovered well after surgery.

Bald men may have a lower risk of testicular cancer.